This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Midday Movers: Pump Up the Volume

NEW YORK ( TheStreet) -- Several small-cap stocks were moving on above-average volume during Wednesday's session.

Speedus (SPDE) surged by $1.27, or 31.4%, to $5.31 after the company said its Zargis Medical subsidiary has been cleared as a developer for Apple's (AAPL - Get Report) iPhone and has begun development of medical diagnostic support software and related peripherals for the device and other leading smartphones. Volume topped 954,000 shares, compared to the 50-day average daily volume of 190,000, according to the Nasdaq.

VeriChip (CHIP) jumped by 69 cents, or 37.1%, to $2.55 after the company said it has entered into a strategic partnership with the Diabetes Research Institute to develop a glucose-sensing RFID microchip, which "could potentially improve patient care and compliance among individuals with diabetes," the DRI said in a statement. Volume topped 6.3 million shares, compared to the 50-day average daily volume of 1.3 million, according to the Nasdaq.

Canada's Oilsands Quest (BQI) rose by 22 cents, or 17.5%, to $1.48 following comments from BP (BP) CEO Tony Hayward, who said the oil giant may increase its drilling position in Canada. "We have a modest position in Canada's oil sands. We can see if we can make it even bigger over time," Hayward told an industry conference in London, according to Dow Jones. Volume topped 11.4 million shares, compared to the 50-day average daily volume of 2.8 million, according to the Nasdaq.

MannKind (MNKD) climbed by 72 cents, or 14.2%, to $5.80 after boutique firm Griffon Securities initiated the stock with a buy rating and a price target of $26. The firm asserted that MannKind's Afresa inhalable treatment will change the way diabetes is treated. Volume topped 3.9 million shares, compared to the 50-day average daily volume of 1.8 million, according to the Nasdaq.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SPDE $0.02 -50.00%
AAPL $126.60 0.15%
CKSW $8.34 -0.95%
GLUU $4.96 -2.36%
MNKD $5.47 -4.54%


DOW 17,856.78 -278.94 -1.54%
S&P 500 2,071.26 -29.78 -1.42%
NASDAQ 4,927.37 -55.4390 -1.11%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs